Allison Breast Center Monument Radiology Safety Alert Announced – This Safety Alert is intended for Patients, Health Professionals, Risk Managers, and Radiology. The U.S. Food and Drug Administration (FDA) is issuing a safety alert for patients who had mammograms at the Allison Breast Center at Monument Radiology, located in Richmond, Virginia, on or after June 17, 2018, due to possible problems with the quality of their mammograms. Allison Breast Center Monument Radiology Safety Alert Background Information – According to the FDA, the facility did not meet the standards for mammography quality under the Mammography Quality Standards Act (MQSA) of 1992. Therefore, the facility may not legally perform mammography at this time, as it does not have an active MQSA certificate reported the FDA. On August 27, 2020, the FDA directed the facility to notify all patients who received mammograms at Read More
FREELEGAL CASE EVALUATION
Please fill out our easy to use form below. We will contact you today. Or, call us 24/7 TOLL FREE at 877-934-6274.News Archives
Nov. 27, 2019: Wrong Patient Receives Kidney Transplant at NJ Hospital
Wrong Patient Receives Kidney Transplant On November 18, 2019, Virtua Our Lady of Lourdes Hospital in Camden, NJ performed a kidney transplant on the wrong patient. The patient who actually received the transplant was a 51-year-old male. Officials stated that this recipient was in need of a kidney, but he was out of priority order based on the matching organ donor list. This individual shared the “same name and is of similar age” as the intended recipient, according to a Virtua Health statement. The patient who was set to get the kidney transplant underwent a successful transplant this past Sunday, November 24. Virtua advised that both individuals are doing well. Surgical and Medical Malpractice Information According to Johns Hopkins, surgical/medical malpractice is the third leading cause of death in the United States. Per the study that Johns Hopkins references, data Read More
November 1, 2018: Adenovirus NJ Outbreak Update, 28 Confirmed Cases At Wanaque Center
Adenovirus NJ Outbreak News On November 1, 2018, the New Jersey Department of Health (DOH) reported that another adenovirus case had been confirmed in an ongoing outbreak at the Wanaque Center for Nursing and Rehabilitation in Haskell. To date, a total of 28 confirmed pediatric adenovirus cases have been associated with the outbreak, resulting in 10 deaths. Illness onset dates related to this outbreak range from September 25, 2018 through October 30, 2018. According to the DOH, the Wanaque facility will not admit new residents while the outbreak is ongoing. In addition, a DOH Communicable Disease Service staff member is on site at the facility to monitor the outbreak. About Adenovirus According to the US Centers for Disease Control and Prevention (CDC), adenoviruses can cause a range of illnesses including cold-like symptoms, sore throat, bronchitis, pneumonia, diarrhea, pink eye (conjunctivitis),fever, Read More
October 25, 2018: NJDOH Investigates Acinetobacter Outbreak at University Hospital, Newark
NJ Acinetobacter Outbreak Announced – The New Jersey Department of Health (DOH) announced that it is investigating four Acinetobacter baumannii infections in the neonatal intensive care unit (NICU) of University Hospital in Newark. About Acinetobacter Acinetobacter is an opportunistic bacterial pathogen mainly affecting people with compromised immune systems. It is a significant healthcare-associated infection. According to the U.S. Centers for Disease Control and Prevention (CDC) Acinetobacter causes a variety of diseases, ranging from pneumonia to serious blood or wound infections, and the symptoms vary depending on the disease.” Acinetobacter can be spread by person-to-person contact or by coming into contact with contaminated surfaces. Infection control procedures, including hand washing and environmental cleaning, can reduce the risk of transmission. New Jersey Department of Health Findings The DOH reports that it first became aware of the Acinetobacter outbreak on October 1, 2018. Read More
November 09, 2016: State Legislative Conference Addresses Painkiller Abuse
2016 State Legislative Conference on Painkiller Abuse From October 27th to 29th the American Academy of Family Physicians (AAFP) held a State Legislative Conference to discuss the way the federal and state governments have addressed the issue of the painkiller abuse epidemic. According to the U.S. Centers for Disease Control and Prevention, sales of prescription opioids in the U.S. nearly quadrupled from 1999 to 2014; deaths from prescription opioids—drugs like oxycodone, hydrocodone, and methadone- have also quadrupled since 1999. Painkiller Abuse and Heroin Addiction In Arizona, from 2005 to 2015, pain killers were the cause of significantly more deaths than deaths attributed to other drugs. In 2015, 405 deaths were caused by pharmaceutical painkiller overdose compared with 237 heroin-related deaths. According to Cara Christ, M.D., M.S., director of the Arizona Department of Health Services, “Seventy-five percent of heroin users started Read More
October 24, 2016: FDA Reports Progress in Opioid Abuse Action Plan
On October 24, 2016, FDA Voice provided an update on the progress of the U.S. Food and Drug Administration (FDA) Opioid Abuse Action Plan. According to Robert M. Califf, M.D., the Deputy Commissioner of the United States Food and Drug Administration’s Office of Medical Products and Tobacco, the plan to address problems with opioid abuse has made significant strides. CONTACT THE WEINBERG LAW FIRM FOR A FREE DRUG LAWSUIT CASE EVALUATION Attorney Eric H. Weinberg has played a significant role in multiple mass tort litigations against corporate pharmaceutical defendants. He has represented plaintiffs in high profile drug lawsuits including Pradaxa, Vioxx, Baycol, and blood clotting products. For a free drug lawsuit evaluation, please call us toll free at 1-877-934-6274, or submit the easy-to-use Free Legal Case Evaluation Form. Our phones are answered 24/7. FDA Opioid Abuse Action Plan Progress At Read More
October 20, 2016: Fainting Spells May Indicate A Serious Blood Clot, New Study Finds
Fainting Pulmonary Embolism According to an Italian study, fainting spells may indicate a blood clot in the lung more often than previously thought. The study, published in the New England Journal of Medicine, found that 17 percent of the patients with fainting spells also had blood clots in the lung. These findings are alarming because physicians typically do not check for blood clots when a patient experiences a fainting spell. Blood Clots, Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) A pulmonary embolism (PE) is a sudden blockage in a lung artery. The blockage is actually a blood clot or blood clots that have traveled to the lungs from another part of the body. These traveling blood clots commonly form in the deep veins of the legs, and are called a deep vein thrombosis (DVT). Because a PE can block Read More
June 7, 2016: Reports of High-Dose Imodium Heart Problems, Warns FDA
High-Dose Imodium Heart Problems The U.S. Food and Drug Administration (FDA) has issued a Drug Safety Communication cautioning the public against taking higher than recommended doses of the common over-the-counter and prescription diarrhea medicine Imodium (loperamide), including through abuse or misuse of the product, as this can cause serious heart problems that can lead to death. Danger Use of higher than recommended doses of Imodium can result in serious cardiac adverse events. High doses of Imodium may cause cardiac events including: QT interval prolongation, Torsades de Pointes other ventricular arrhythmias, syncope, and cardiac arrest. Details of High-Dose Imodium Heart Problems Imodium is used to help control symptoms of diarrhea, including Travelers’ Diarrhea. The maximum approved daily dose for adults is 8 mg per day for OTC use and 16 mg per day for prescription use. It is sold under the Read More
June 6, 2016: FDA Warns Consumers of Aspirin-Antacid Bleeding Risk
Aspirin-Antacid Bleeding Risk The U.S. Food and Drug Administration (FDA) is warning consumers about the risk of serious bleeding when using nonprescription, also known as over-the-counter or OTC, aspirin-containing antacid products to treat heartburn, sour stomach, acid indigestion, or upset stomach. Aspirin is a commonly used pain reducer and fever reducer. It is a nonsteroidal anti-inflammatory drug (NSAID) that can increase the risk of bleeding, including in the stomach and gastrointestinal (GI) tract. In a Safety Communication issued on June 6, 2016, The U.S. Food and Drug Administration (FDA) publicized the risk of serious bleeding when using over-the-counter (nonprescription) aspirin-containing antacid products. The FDA cautioned consumers to consider this risk when looking for an antacid to treat heartburn, sour stomach, acid indigestion, or upset stomach. Aspirin is a commonly used pain reducer and fever reducer, but may increase the risk Read More
June 3, 2016: Letter Reveals Negligence Behind the Pasadena Hospital Duodenoscope Superbug Outbreak
Pasadena Hospital Duodenoscope Superbug Outbreak One hospital in California which had suffered a duodenoscope superbug outbreak released a letter revealing the hospital’s own negligence in reporting the outbreak. Huntington Hospital in Pasadena, California broke state law by not quickly reporting a suspected deadly outbreak last year. The duodenoscope superbug outbreak sickened 16 patients, 11 of whom died, from the first patient case in January 2013 to August 2015. Duodenoscope Infection Lawsuit Help The Law Firm of Eric H. Weinberg is assisting individuals nationwide who may have suffered an infection following an endoscopic procedure known as ERCP. Since 1984, Attorney Weinberg has represented personal injury victims, including those injured by defective medical devices, including metal-on-metal hip joints, transvaginal mesh, and apnea monitors. For a free legal case evaluation, please call our law firm toll free at 1-877-934-6274. . Pasadena Hospital Duodenoscope Read More